We are virtually at the European Arteriosclerosis Society congress
This week the 88th edition of the Congress of the European Arteriosclerosis Society was held in virtual format. The congress has included a large number of basic and clinical research presentations by members of the scientific community. Our research team has participated with the presentation of two Science at a Glance and a poster in […]
Glycoprotein Profile Assessed by 1H-NMR as a Global Inflammation Marker in Patients with HIV Infection. A Prospective Study.
Abstract Plasma glycoproteins are a composite biomarker of inflammation and can be detected by 1H-NMR. The aim of this study was to prospectively appraise the clinical value of plasma glycoproteins assessed by 1H-NMR in people living with HIV (PLWH). A total of 221 patients with HIV infection were recruited and studied at baseline and at 48 […]
A Global Meeting for a Safer World
COVID-19 Hackathon #Endocrine Disruption, #Text mining in #Toxicology, #Bioinformatics #Metabolomics for #biomarker #discovey, #Organ-on-Chip testing… and more We have participated in the #OpenTox Virtual conference: https://www.opentox.net/events/virtual-conference-2020/program Our poster
Predicting the future of health
Once infected by SARS-CoV-2, would you like to know your health status evolution? This is Biosfer Teslab commitment in the SARS-CoV-2 pandemic. The Spanish Institute of Health Research Pere Virgili, Fundación Alcorcón University Hospital, SCIENCE&STRATEGY SL, Laboratorios Rubió SA, and Biosfer Teslab together with Treat systems (Denmark), Kinesys Consulting (UK), EuroCrime (Italy) have built […]
Alberto Elzaburu Foundation award
The sixth edition of the Alberto Elzaburu Foundation Innovation Award recognizes Núria Amigó, CEO of Biosfer Teslab, as a young entrepreneur The Alberto Elzaburu Foundation, for the sixth consecutive year, granted yesterday November 5 at the Mapfre Auditorium in Madrid, its Innovation Award, which recognizes the efforts of young Spanish entrepreneurs and researchers and values […]
Biosfer Teslab presents its first industrial doctoral thesis
The student Rocío Fuertes has obtained a doctoral degree from the University Rovira i Virgili after defending her thesis “1H-NMR glycoprotein analysis: An Advanced approach for Inflammatory diseases diagnosis”, for which she has achieved the status of ‘cum laude’ by unanimity of the court. Developed between Biosfer Teslab -within the framework of the Industrial Doctorate […]
Disruptive innovations and start-ups
Last December, Núria Amigó took part in the round table on “Disruptive innovations and start-ups”. You can see her speech here (video in Catalan)
LDL cholesterol: the poison is stored in small bottles
Dr. Adriana Saltijeral of the University Hospital del Tajo (Aranjuez, Madrid) interviews Dr. Leopoldo Pérez de Isla, of the San Carlos Clinical Hospital of Madrid and member of the Scientific Committee of the Family Hypercholesterolemia Foundation, to talk about the importance of knowing the size of LDL cholesterol particles to stratify cardiovascular risk. Dr. Pérez […]
Standard values of number and size of lipoprotein particles per age and gender, using Nuclear Magnetic Resonance
The XXIX Convention of the Spanish Atherosclerosis Society (SEA) took place in Granada last May, and its scientific committee chose another of the I+D projects developed in Biosfer Teslab to be presented as an oral communication. The Communication title is “Standard values of number and size of lipoprotein particles per age and gender, using Nuclear […]
Metabolomics characterization for patients with Rheumatoid Arthritis using spectroscopy
In May, the XXIX Convention of the Spanish Atherosclerosis Society (SEA) took place in Granada, and its scientific committee chose one of the I+D projects developed in Biosfer Teslab to be presented as an oral communication. The presented Communication, whose title is “MEtabolomics characterization for patients with Rheumatoid Arthritis (RA) using 1H-Nuclear magnetic resonance (1H […]
